Dr. Suryavathi Viswanadhapalli is an Assistant Professor at the Department of Obstetrics and Gynecology, University of Texas Health San Antonio, USA. She obtained her Doctorate in Reproductive Toxicology from the University of Rajasthan, India, and finished her postdoctoral fellowship at the University of Virginia, where she focused on the genetic causes of infertility and endocrine disorders. She further expanded her expertise with a second post-doctoral fellowship at UT Health, specializing in hormonal carcinogenesis, therapy resistance, and drug development using endometrial, breast, and ovarian cancer models. Her current research interests include developing small molecules targeting novel oncogenes, elucidating the mechanisms of the action of new drugs, utilizing CRISPR/Cas9 screens, studying mechanisms of therapy resistance, and creating preclinical models of cancer progression, such as patient-derived explants (PDeX), organoids (PDO’s), and xenografts (PDX).